Skip to main content

Table 1 Patient characteristics

From: Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study

Karnofsky performance status (median (range))

60 (40–80)

Cancer Diagnoses

 

   Prostate

11

   Colorectal

5

   Kidney

3

   Breast

3

   Pancreatic

2

   Lung

2

   Gastric

1

   Malignant melanoma

1

   Leiomyosarcoma

1

Metastases

 

   Liver

7

   Bone

16

   Other

16

Antidepressants

4

Neuroleptics

1

Benzodiazepines

6

Corticosteroids

13

Antiemetics

7